TAK-755 not checked
Takeda · Recombinant ADAMTS13 · BAX 930
FollowEvery change as it happens, and a Monday email
Trials
2 active
7 in total · 3 in the EU
What this is
- How it works
- How it works isn't classified yet
- Main trialPhase 3
- “Thrombotic thrombocytopenic purpura (or TTP for short) is a condition where blood clots form in small blood vessels throughout the body. The clots can limit or block the flow of oxygen-rich blood to the body's organs, such as the brain, kidneys, and heart. As a result, serious health problems can develop. The increased clotting that occurs in TTP uses up the cells that help the blood to clot, called platelets. With fewer platelets available in the blood, bleeding problems can also occur. People who have TTP may bleed underneath the skin forming purple bruises, or purpura. TTP also can cause…”In the company’s words, NCT04683003 on ClinicalTrials.gov
- Other names
- Recombinant ADAMTS13 · BAX 930 · SHP655 · rADAMTS13
Other drugs for Acute Ischemic Stroke
- Neuroncell-EXCytopeutics Sdn. Bhd. · Phase 2/3
- DM199DiaMedica Therapeutics Inc · Phase 2/3
- SP-8203Shin Poong Pharmaceutical Co. Ltd. · Phase 3
- SHPL-49Shanghai Hutchison Pharmaceuticals Limited · Phase 3
- RhTNK-tPACSPC · Phase 3
- SovateltidePharmazz, Inc. · Phase 3
Coming up2
- 16 Mar 2027Phase 3 trial completes · ClinicalTrials.gov
- 6 Dec 2027Phase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials7
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Active, not recruiting | 16 Mar 2027 | A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura | |
| Phase 2Recruiting | 6 Dec 2027 | A Study of TAK-755 in Adults With Acute Ischemic Stroke | |
| Phase 3Completed | 28 Dec 2023 | A Study of BAX 930 in Children, Teenagers, and Adults Born With Thrombotic Thrombocytopenic Purpura (TTP) | |
| Phase 2Completed | 5 Aug 2021 | Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) | |
| Phase 2Completed | 16 Apr 2026 | A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP) | |
| Phase 1Completed | 22 Feb 2016 | Phase 1 Dose Escalation, Single Dose Study to Assess Safety and Pharmacokinetics of BAX930 in Hereditary Thrombotic Thrombocytopenic Purpura (TTP) | |
| Phase 1Completed | 26 Oct 2022 | A Study of SHP655 (rADAMTS13) in Sickle Cell Disease |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026